Table 2.
PROM | Clinical detail | Median Score (IQR) |
P value |
---|---|---|---|
UW-QOL | Male | 71 (61 – 82) | p = 0.0076 |
Physical | Female | 59 (45 – 69) | |
Surgery alone | 72 (63 – 82) | p = 0.0401 | |
Surgery + RT | 61 (45 – 85) | ||
Surgery + CRT | 63 (48 – 71) | ||
Stage I | 71 (46 – 88) | p = 0.9005 | |
Stage II | 68 (64 – 74) | ||
Stage III | 61 (57 – 72) | ||
Stage IV | 67 (47 – 78) | ||
Primary disease | 67 (52 – 78) | p = 0.835 | |
Recurrence or 2nd | 65 (54 – 73) | ||
primary | |||
UW-QOL Social | Male | 82 (70 – 91) | p = 0.003 |
Female | 64 (61 – 82) | ||
Surgery alone | 87 (65 – 92) | p = 0.18 | |
Surgery + RT | 80 (64 – 88) | ||
Surgery + CRT | 70 (62 – 82) | ||
Stage I | 78 (66 – 96) | p = 0.8498 | |
Stage II | 79 (64 – 82) | ||
Stage III | 73 (61 – 87) | ||
Stage IV | 72 (64 – 87) | ||
Primary disease | 75 (63 – 87) | p = 0.8665 | |
Recurrence or 2nd | 72 (63 – 92) | ||
primary | |||
EAT-10 | Male | 7 (2 – 18) | p = 0.0706 |
Female | 16 (4 – 26) | ||
Surgery alone | 6 (2 – 10) | p = 0.2837 | |
Surgery + RT | 11 (2 – 27) | ||
Surgery + CRT | 12 (4–23 | ||
Stage I | 6 (2 – 22) | p = 0.3947 | |
Stage II | 4 (2 – 21) | ||
Stage III | 12 (0 – 27 | ||
Stage IV | 10 (4 – 26) | ||
Primary disease | 10 (2 – 21) | p = 0.3394 | |
Recurrence or 2nd | 10 (4–25 | ||
primary |